Future Data Will Determine the Effectiveness of the New Alzheimer’s Drug
Dr. Keith Vossel, Neurologist and Director of the Easton Center, was quoted in a San Francisco Chronicle July 7th article about more observations and real-world data needed to determine the effectiveness of the newly approved Alzheimer’s drug, Leqembi.
Read San Francisco Chronicle Article
Related Articles
UCLA Develops New Alzheimer's Disease Therapeutic
Dr. Varghese John, Dr. Istvan Mody, and colleagues were highlighted in a UCLA article about their recent therapeutic development, targeting ...
A More Inclusive Framework for Alzheimer’s Disease
The Easton Center, ELHA Lab, UCLA Neurology, Alzheimer's Los Angeles, and community leaders are working together bridging the gap between health disparities ...
Healthy Body. Healthy Mind.
In the Summer Edition of Keiro Connect, Dr. Kevin Bickart discussed physical activity, including dancing, to improve brain health and prevent dementia ...
An In-Depth Interview on Various Neurodegenerative Diseases
Dr. Keith Vossel was interviewed by Dr. Marc Siegel from Doctor Radio/Sirius XM about a wide spectrum of neurodegenerative diseases, including ...